Long-chain acyl coenzyme a synthetase 1 overexpression in primary cultured schwann cells prevents long chain fatty acid-induced oxidative stress and mitochondrial dysfunction

Antioxidants and Redox Signaling

Volumn 21, Issue 4, 2014, Pages 588-600

  Hinder, Lucy M ^a   Figueroa Romero, Claudia ^a   Pacut, Crystal ^a   Hong, Yu ^a   Vivekanandan Giri, Anuradha ^a   Pennathur, Subramaniam ^a   Feldman, Eva L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CARNITINE DERIVATIVE; LINOLEIC ACID; LONG CHAIN ACYL COENZYME A SYNTHETASE 1; LONG CHAIN FATTY ACID; LONG CHAIN FATTY ACID COENZYME A LIGASE; OLEIC ACID; PALMITIC ACID; UNCLASSIFIED DRUG; ACSL1 PROTEIN, MOUSE; FATTY ACID;

ACSL1 GENE; ANIMAL CELL; CELL SURVIVAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEUROPATHY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FATTY ACID OXIDATION; GENE; GENE OVEREXPRESSION; HYPERLIPIDEMIA; IN VITRO STUDY; LIPOTOXICITY; METABOLIC ACTIVATION; MOUSE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PERIPHERAL NERVE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTON TRANSPORT; REVIEW; SCHWANN CELL; UPREGULATION; ANIMAL; CELL CULTURE; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION; GENETICS; HUMAN; HYPERTRIGLYCERIDEMIA; METABOLISM; MITOCHONDRION; PRIMARY CELL CULTURE; RAT;

ANIMALS; CELLS, CULTURED; COENZYME A LIGASES; DIABETIC NEUROPATHIES; DISEASE MODELS, ANIMAL; FATTY ACIDS; GENE EXPRESSION; HUMANS; HYPERTRIGLYCERIDEMIA; MICE; MITOCHONDRIA; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PRIMARY CELL CULTURE; RATS; SCHWANN CELLS;

EID: 84904006203     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5248     Document Type: Review

References (41)

1. Ansquer JC, Foucher C, Aubonnet P, and Le Malicot K. Fibrates and microvascular complications in diabetes-insight from the FIELD study. Curr Pharm Des 15: 537-552, 2009.
2. Arnoult D, Grodet A, Lee YJ, Estaquier J, and Blackstone C. Release of OPA1 during apoptosis participates in the rapid and complete release of cytochrome c and subsequent mitochondrial fragmentation. J Biol Chem 280: 35742-35750, 2005.
3. Assimacopoulos-Jeannet F, Thumelin S, Roche E, Esser V, McGarry JD, and Prentki M. Fatty acids rapidly induce the carnitine palmitoyltransferase I gene in the pancreatic betacell line INS-1. J Biol Chem 272: 1659-1664, 1997.
4. Brand MD and Nicholls DG. Assessing mitochondrial dysfunction in cells. Biochem J 435: 297-312, 2011.
5. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820, 2001.
6. CDCP. National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA, 2011.
7. Clemens A, Siegel E, and Gallwitz B. Global risk management in type 2 diabetes: Blood glucose, blood pressure, and lipids-update on the background of the current guidelines. Exp Clin Endocrinol Diabetes 112: 493-503, 2004.
8. Eckersley L. Role of the Schwann cell in diabetic neuropathy. Int Rev Neurobiol 50: 293-321, 2002.
9. Edwards JL, Quattrini A, Lentz SI, Figueroa-Romero C, Cerri F, Backus C, Hong Y, and Feldman EL. Diabetes regulates mitochondrial biogenesis and fission in mouse neurons. Diabetologia 53: 160-169, 2010.
10. Edwards JL, Vincent AM, Cheng HT, and Feldman EL. Diabetic neuropathy: Mechanisms to management. Pharmacol Ther 120: 1-34, 2008.
11. Hinder LM, Vincent AM, Hayes JM, McLean LL, and Feldman EL. Apolipoprotein E knockout as the basis for mouse models of dyslipidemia-induced neuropathy. Exp Neurol 239: 102-110, 2013.
12. Hinder LM, Vivekanandan-Giri A, McLean LL, Pennathur S, and Feldman EL. Decreased glycolytic and tricarboxylic acid cycle intermediates coincide with peripheral nervous system oxidative stress in a murine model of type 2 diabetes. J Endocrinol 216: 1-11, 2013.
13. Hur J, Sullivan KA, Pande M, Hong Y, Sima AA, Jagadish HV, Kretzler M, and Feldman EL. The identification of gene expression profiles associated with progression of human diabetic neuropathy. Brain 134: 3222-3235, 2011.
14. Lee K, Kerner J, and Hoppel CL. Mitochondrial carnitine palmitoyltransferase 1a (CPT1a) is part of an outer membrane fatty acid transfer complex. J Biol Chem 286: 25655-25662, 2011.
15. Lorenz MA, Burant CF, and Kennedy RT. Reducing time and increasing sensitivity in sample preparation for adherent Mammalian cell metabolomics. Anal Chem 83: 3406-3414, 2011.
16. Low PA, Nickander KK, and Trischler HJ. The roles of oxidative stress and antioxidant treatment in experimental diabetic neuropathy. Diabetes 46 (2S): 38S-42S, 1997.
17. Mashek DG, Li LO, and Coleman RA. Long-chain acyl-CoA synthetases and fatty acid channeling. Future Lipidol 2: 465-476, 2007.
18. Miller TA, LeBrasseur NK, Cote GM, Trucillo MP, Pimentel DR, Ido Y, Ruderman NB, and Sawyer DB. Oleate prevents palmitate-induced cytotoxic stress in cardiac myocytes. Biochem Biophys Res Commun 336: 309-315, 2005.
19. Osawa T and Kato Y. Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia. Ann N Y Acad Sci 1043: 440-451, 2005.
20. Padilla A, Descorbeth M, Almeyda AL, Payne K, and De Leon M. Hyperglycemia magnifies Schwann cell dysfunction and cell death triggered by PA-induced lipotoxicity. Brain Res 1370: 64-79, 2011.
21. Pande M, Hur J, Hong Y, Backus C, Hayes JM, Oh SS, Kretzler M, and Feldman EL. Transcriptional profiling of diabetic neuropathy in the BKS db/db mouse: A model of type 2 diabetes. Diabetes 60: 1981-1989, 2011.
22. Readnower RD, Brainard RE, Hill BG, and Jones SP. Standardized bioenergetic profiling of adult mouse cardiomyocytes. Physiol Genomics 44: 1208-1213, 2012.
23. Roy Chowdhury SK, Smith DR, Saleh A, Schapansky J, Marquez A, Gomes S, Akude E, Morrow D, Calcutt NA, and Fernyhough P. Impaired adenosine monophosphateactivated protein kinase signalling in dorsal root ganglia neurons is linked to mitochondrial dysfunction and peripheral neuropathy in diabetes. Brain 135: 1751-1766, 2012.
24. Russell JW, Sullivan KA, Windebank AJ, Herrmann DN, and Feldman EL. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol Dis 6: 347-363, 1999.
25. Sullivan KA, Hayes JM, Wiggin TD, Backus C, Su Oh S, Lentz SI, Brosius F, 3rd, and Feldman EL. Mouse models of diabetic neuropathy. Neurobiol Dis 28: 276-285, 2007.
26. Tomlinson DR and Gardiner NJ. Glucose neurotoxicity. Nat Rev Neurosci 9: 36-45, 2008.
27. van der Leij FR, Huijkman NC, Boomsma C, Kuipers JR, and Bartelds B. Genomics of the human carnitine acyltransferase genes. Mol Genet Metab 71: 139-153, 2000.
28. Verheijen MH, Chrast R, Burrola P, and Lemke G. Local regulation of fat metabolism in peripheral nerves. Genes Dev 17: 2450-2464, 2003.
29. Viader A, Golden JP, Baloh RH, Schmidt RE, Hunter DA, and Milbrandt J. Schwann cell mitochondrial metabolism supports long-term axonal survival and peripheral nerve function. J Neurosci 31: 10128-10140, 2011.
30. Vincent AM, Callaghan BC, Smith AL, and Feldman EL. Diabetic neuropathy: Cellular mechanisms as therapeutic targets. Nat Rev Neurol 7: 573-583, 2011.
31. Vincent AM, Edwards JL, McLean LL, Hong Y, Cerri F, Lopez I, Quattrini A, and Feldman EL. Mitochondrial biogenesis and fission in axons in cell culture and animal models of diabetic neuropathy. Acta Neuropathol 120: 477-489, 2010.
32. Vincent AM and Feldman EL. New insights into the mechanisms of diabetic neuropathy. Rev Endocr Metab Disord 5: 227-236, 2004.
33. Vincent AM, Hayes JM, McLean LL, Vivekanandan-Giri A, Pennathur S, and Feldman EL. Dyslipidemia-induced neuropathy in mice: The role of oxLDL/LOX-1. Diabetes 58: 2376-2385, 2009.
34. Vincent AM, Hinder LM, Pop-Busui R, and Feldman EL. Hyperlipidemia: A new therapeutic target for diabetic neuropathy. J Peripher Nerv Syst 14: 257-267, 2009.
35. Vincent AM, Kato K, McLean LL, Soules ME, and Feldman EL. Sensory neurons and schwann cells respond to oxidative stress by increasing antioxidant defense mechanisms. Antioxid Redox Signal 11: 425-438, 2009.
36. Vincent AM, McLean LL, Backus C, and Feldman EL. Shortterm hyperglycemia produces oxidative damage and apoptosis in neurons. FASEB J 19: 638-640, 2005.
37. Vincent AM, Olzmann JA, Brownlee M, Sivitz WI, and Russell JW. Uncoupling proteins prevent glucose-induced neuronal oxidative stress and programmed cell death. Diabetes 53: 726-734, 2004.
38. Vincent AM, Perrone L, Sullivan KA, Backus C, Sastry AM, Lastoskie C, and Feldman EL. Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 148: 548-558, 2007.
39. Vincent AM, Russell JW, Low P, and Feldman EL. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev 25: 612-628, 2004.
40. Wiggin TD, Sullivan KA, Pop-Busui R, Amato A, Sima AAF, and Feldman EL. Elevated triglycerides correlate with progression of diabetic neuropathy. Diabetes 58: 1634-1640, 2009.
41. Zhang L, Yu C, Vasquez FE, Galeva N, Onyango I, Swerdlow RH, and Dobrowsky RT. Hyperglycemia alters the schwann cell mitochondrial proteome and decreases coupled respiration in the absence of superoxide production. J Proteome Res 9: 458-471, 2010.